New antibiotic use summary to help tackle antimicrobial resistance A Therapeutic Guidelines summary table of antibiotic use in primary care has been freely distributed to general practices.
Food labelling: When is a medicine not a medicine? Concerns have been raised over alleged double standards regarding the regulation of food products promoted as having ‘special medical purposes’.
WHO releases new guidelines on preventing dementia The guidelines evaluate 12 risk factors and are designed to help governments and healthcare providers tackle dementia prevention.
TGA criticised over lack of safety warnings Questions have been raised over the way Australia’s therapeutic regulator is informing doctors and patients about potentially dangerous drugs.
Codeine supply in Australia has almost halved The massive decrease has been attributed to the 2018 decision to up-schedule codeine to a Schedule 4 prescription-only medicine.
Why down-scheduling medicines is fraught with danger Assoc Prof Mark Morgan questions whether a push to make more prescription-only medicines available over the counter is best for patients.
It may be ‘natural’, but is it healthy? RACGP supports the TGA’s move to ensure advertising claims of ‘natural’ ingredients in therapeutic goods are not misleading.
Safety concerns over popular arthritis drug The TGA issued an alert after a study found high doses of tofacitinib could lead to increased risk of blood clots in the lungs and potentially death.
TGA moves to ease fears over a ‘no deal’ Brexit Imported medicines and devices will be minimally affected under a ‘no deal’ Brexit, according to the Therapeutic Goods Administration.
World-first guideline for work-related mental health conditions People experiencing work-related mental health issues take up to three times longer to return to work than those with physical injuries.